Growth Hormone Resistance of Beta-cells

Part of paid clinical trials in Columbia, Missouri.

Sponsor
University of Missouri-Columbia
Study ID
NCT07581860
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Healthy
  • Impaired Fasting Glucose (IFG)
  • Impaired Glucose Tolerance (Prediabetes)
  • Obesity & Overweight

Eligibility Criteria

Sex
ALL
Age
18 Years - 59 Years
Healthy Volunteers
Not accepted

Study Details

The purpose of the research study is to better understand how beta-cells (cells in the pancreas that make insulin and help regulate blood sugar) respond to growth hormone in people with impaired fasting glucose or impaired glucose tolerance at the University of Missouri. The aim of the study is to advance understanding of how growth hormone affects beta-cells and risk factors for developing type 2 diabetes.

Key Dates

Start date
Aug 1, 2026
Status verified
May 2026
Primary completion
Sep 1, 2028
Completion
Sep 1, 2030

Study Design

Enrollment
10 participants (estimated)

Arms

  • Arm: Impaired fasting glucose
  • Arm: Impaired glucose tolerance

Primary Outcome Measure

Beta-cell function [ Time Frame: before and 7 days after rhGH administration ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Missouri School of MedicineColumbiaMissouri65212
Study coordinator
[email protected]
573-884-6852

Find similar trials in Columbia, MO

By research site
University of Missouri School of Medicine· Columbia, MO

Related Studies